Recent progress in TKS4-related research has revealed that the effect of TKS4 might also be implicated in several cancer types, including breast cancer [13], melanoma [9], acute myeloid leukemia [14], hepatocellular carcinoma [15] and prostate cancer [16]. This evidence concerns the gene SH3PXD2B and acute myeloid leukemia.